MTOR and non-small cell lung carcinoma: As our study shows, AA treatment enhanced ROS accumulation activates AMPK-suppressing mTOR and thereby induced NSCLC cell apoptosis; a phenomenon that was abolished in the presence of both the antioxidant agent NAC and an AMPK inhibitor (Figure 4C and Figure 5).